News — Canadian Sepsis Foundation
A free online congress by the GSA. Three Major Scientific Societies Confirm Link Between SARSCoV-2 and Sepsis, Which Causes Vast Majority of COVID-19 Deaths.
www.canadiansepsisfoundation.caI don’t have live access to current events in this turn, but I can summarize recent trends and notable developments in sepsis up to mid-2026 based on trustworthy sources.
Key trends in sepsis news
- Global initiatives and collaborations: There are ongoing international efforts to coordinate sepsis response, including partnerships between major organizations like the Global Sepsis Alliance, SCCM, ESICM, and WHO to accelerate research, diagnostics, and treatment access.[2][3]
- Diagnostics and biomarkers: Rapid diagnostic tests that distinguish bacterial from non-bacterial infections and point toward targeted antibiotic therapy are a major focus, with investments and prize programs aimed at accelerating availability of these tools. These developments aim to shorten time to appropriate treatment and reduce sepsis progression.[1]
- AI and precision medicine: AI-driven approaches and biomarker-guided strategies are being explored to detect sepsis earlier and tailor therapies to individual immune responses, including personalized immunotherapy trials like IMMUNOSEP being discussed in European initiatives.[1][2]
- Clinical research and trials: Large-scale trials and multicountry studies continue to investigate targeted therapies and immune modulation in sepsis, with attention to heterogeneity in patient immune states and the potential for improved survival and reduced complications.[3][2]
- Public and policy attention: Sepsis remains a high-priority patient safety and public health issue, with coverage of new guidelines, hospital alert systems, and digital tools to improve early recognition and treatment pathways in health systems such as the NHS and other national programs.[9][3]
Recent highlights you might want to explore
- A landmark collaboration announced in 2026 to strengthen sepsis research and response globally, with WHO support and substantial funding for therapeutics and diagnostic development (Europe-based sources mention a €244 million budget call related to viral infections and sepsis).[2]
- Reports of AI-enabled sepsis detection tools making progress in hospital settings, including systems that analyze blood test results and vital signs to flag sepsis early for timely intervention.[5]
If you’d like, I can:
- Pull the latest headlines from specific regions (US, UK, Europe) and summarize the top 3–5 sepsis stories.
- Create a concise briefing with key players, recent trial names, and what to watch for in the next 3–6 months.
- Compile a short glossary of new diagnostic and therapeutic terms cited in these updates.
Would you like me to focus on a particular region or provide a quick, curated briefing with citations?